4//SEC Filing
Hoenlein Malcolm 4
Accession 0001104659-23-001095
CIK 0001429260other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 9:24 PM ET
Size
14.3 KB
Accession
0001104659-23-001095
Insider Transaction Report
Form 4
Hoenlein Malcolm
Director
Transactions
- Award
COMMON STOCK, PAR VALUE $0.001
2023-01-01+50,000→ 535,636 total
Footnotes (2)
- [F1]One-third of the shares will vest on each of January1, 2024, 2025 and 2026, subject to continued service. The Reporting Person elected to defer 100% of these restricted shares pursuant to the Issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the Reporting Person in January of the year following the reporting person's termination of service, or earlier upon his death or change in control of the Issuer.
- [F2]The total holdings include 450,000 shares underlying deferred restricted stock units.
Issuer
Fortress Biotech, Inc.
CIK 0001429260
Entity typeother
Related Parties
1- filerCIK 0001294517
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 9:24 PM ET
- Size
- 14.3 KB